# IBANDRONATE SODIUM

NDC: 69452-378
Generic name: IBANDRONATE SODIUM
Labeler / Manufacturer: Bionpharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230526

FDA application: ANDA078998

## Active ingredients

- IBANDRONATE SODIUM: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69452-378"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69452-378
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ca94cce-a2bb-421f-bd8f-6b14bc2bd985